A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
Oral therapies for psoriasis, including methotrexate and acitretin, are often less effective
when used as monotherapy (without other oral medicines or creams) than are newer biologic
injected drugs. However, these oral medications are also less expensive than biologic agents
and may be safer for use in some patients. The purpose of this study is to determine if
adding a topical psoriasis medicine, calcipotriene/betamethasone topical suspension (Taclonex
topical suspension), will improve the severity of psoriasis in patients already on
methotrexate or acitretin and to determine if adding this topical suspension will reduce the
desire of such patients to switch to a biologic agent to treat their psoriasis.